The Latest: 'Pharma Bro' jury to begin deliberations Monday

Former biotech CEO Martin Shkreli, right, leaves federal court with a member of his legal team Thursday, July 27, 2017, in New York. Shkreli's defense attorney, Benjamin Brafman, told the jury during closing arguments that his client annoyed some of his investors but ultimately rewarded them by starting a drug company that doubled or tripled their money. (AP Photo/Julie Jacobson)

NEW YORK — The Latest on the securities fraud trial of Martin Shkreli (all times local):

4 p.m.

Jurors at the securities fraud trial of "Pharma Bro" Martin Shkreli will begin deliberations on Monday.

A judge instructed the jury on the law for most of the afternoon on Friday before sending jurors home for the weekend.

Earlier in the day, the jury heard closing arguments by prosecutors accusing the former pharmaceutical CEO looted his own drug company to pay back disgruntled investors in two failed hedge funds he ran. The defense insisted there are no victims because everyone got their original investments back and even made hefty profits.

The 34-year-old Shkreli is best known for jacking up the price of a life-saving drug by 5,000 percent and for trolling his critics online.

___

11 a.m.

A prosecutor says a securities fraud trial has exposed "Pharma Bro" Martin Shkreli as a "con man."

Assistant U.S. Attorney Jacquelyn Kasulis said in closing arguments Friday that the evidence at the trial in federal court in New York City proved the former pharmaceutical CEO looted his own drug company to pay back disgruntled investors in two failed hedge funds he ran.

The defense argued that a drug company official who testified for the government was biased because if Shkreli is found guilty of a felony, the company could justify his firing in 2014 and gain ammunition in its $65 million lawsuit against him.

Shkreli is best known for jacking up the price of a life-saving drug by 5,000 percent and for trolling his critics online.

___

This story has been corrected to show that $65 million refers to damages sought in a lawsuit, not a $65 million stake in a drug company.

Must Read

WHY IT MATTERS: Health Care

Aug 11, 2016

WHY IT MATTERS: A record 9 in 10 Americans now have health insurance but costs are rising and progress is incomplete

Ali tribute book to be released by Jeter imprint

Aug 11, 2016

A very great athlete will help pay tribute to "The Greatest": Derek Jeter's publishing imprint is set to release "Muhammad Ali Unfiltered." Publication is scheduled for October

Kohl's 2Q profit tops expectations as it lowers expenses

Aug 11, 2016

Kohl's 2Q profit beat analysts' expectations as the department store operator reduced expenses and managed its inventory well

People also read these

Asian shares climb, tracking gains in US stocks, oil prices

Aug 12, 2016

Asian shares rose Friday, tracking the rally in U.S. stocks that was driven by strong gains by energy companies and retailers

Clinton knocks 'outlandish Trumpian ideas' in policy speech

Aug 11, 2016

Hillary Clinton sought to undercut Donald Trump's claim to working class voters Thursday, portraying her Republican rival as untrustworthy on economic issues, and pushing policies that would only benefit the super-wealthy _ himself included

Ali tribute book to be released by Jeter imprint

Aug 11, 2016

A very great athlete will help pay tribute to "The Greatest": Derek Jeter's publishing imprint is set to release "Muhammad Ali Unfiltered." Publication is scheduled for October